Cargando…

One anastomosis gastric bypass surgery in Type2 diabetes patients with body mass index < 35 kg/m(2): A multi-center retrospective cohort study

INTRODUCTION: Bariatric surgeries have shown efficacy in weight reduction, glycemic control and improvement of type-2 diabetes (T2DM) in patients with obesity. We aimed to assess the efficacy of one anastomosis gastric bypass surgery (OAGB) in T2DM patients with body mass index (BMI) < 35 kg/m(2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Amirbeigi, Alireza, Abbaslou, Fereshteh, Talebpour, Mohammad, Soroush, Ahmadreza, Elyasinia, Fezzeh, Zabihi Mahmoudabadi, Hossein, Najjari, Khosrow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289504/
https://www.ncbi.nlm.nih.gov/pubmed/35860068
http://dx.doi.org/10.1016/j.amsu.2022.104102
Descripción
Sumario:INTRODUCTION: Bariatric surgeries have shown efficacy in weight reduction, glycemic control and improvement of type-2 diabetes (T2DM) in patients with obesity. We aimed to assess the efficacy of one anastomosis gastric bypass surgery (OAGB) in T2DM patients with body mass index (BMI) < 35 kg/m(2) within a year after surgery. METHODS: In this multicenter retrospective cohort study, 14 T2DM patients with BMI <35 kg/m(2) (females, %: 71.4% (10 of 14), and age, mean (standard deviation): 51.2 (12.3) years) who had underwent OAGB surgery by the same surgeon, were followed at intervals of one, three, six, and 12 months after surgery. The remission rates of T2DM were calculated and the metabolic indices were compared using paired t-test and Wilcoxon rank test. RESULTS: No adverse outcomes were detected 12 months after surgery. Within six months, seven (50%) patients underwent remission (one (7.1%) within one, three (21.4%) within three, and three (21.4%) within six months). Post-operative weight (p < 0.001) and fasting blood glucose (p < 0.01) in all time periods were significantly lower compared to pre-operative values. Hemoglobin A1C (HbA1C) was significantly lower at three- and six-month intervals (p < 0.05) but not at twelve months (p = 0.2). Thyroid-stimulating hormone and triglyceride levels were lower at six months compared to pre-surgical levels (p < 0.05) but cholesterol levels were not different in any of time points (p > 0.05). CONCLUSION: OAGB surgery is associated with weight reduction, glycemic control and a 50% remission rate within six months in patients with diabetes and BMI <35 kg/m(2).